Is Gait Speed and Sarcopenia Prognostic in Chronic Respiratory Disease?

NCT02261337 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 565

Last updated 2022-11-01

No results posted yet for this study

Summary

This study aims to assess usual walking speed (4-metre gait speed) and markers of sarcopenia predict mortality in patients with chronic respiratory disease.

Conditions

  • Chronic Obstructive Pulmonary Disease and Allied Conditions

Sponsors & Collaborators

Principal Investigators

  • William DC Man, FRCP PhD · NIHR Respiratory Biomedical Research Unit Royal Brompton & Harefield NHS Foundation Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2018-04-30
Completion
2022-04-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02261337 on ClinicalTrials.gov